Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "104.77",
    "chg": -3.14,
    "chgp": "-2.91%",
    "dir": -1,
    "prev_price": "107.91",
    "mcapval": "173.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "07:58 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "40.18 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-hold-by-marketsmojo-4203494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_mojoScore_4203494.png",
        "date": "2026-09-24 10:11:20",
        "description": "Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Valuation Shift Signals Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-shift-signals-renewed-price-attractiveness-4201589",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_valuationdot_4201589.png",
        "date": "2026-09-23 08:00:24",
        "description": "Bal Pharma Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a more favourable price point relative to its historical and peer benchmarks. This recalibration comes amid a mixed performance in the Pharmaceuticals & Biotechnology sector, with Bal Pharma’s micro-cap status and recent market movements positioning it as a stock worthy of closer investor scrutiny."
      },
      {
        "title": "Bal Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4193896",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_valuationdot_4193896.png",
        "date": "2026-09-16 08:00:51",
        "description": "Bal Pharma Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors within the Pharmaceuticals & Biotechnology sector. This upgrade comes amid mixed sector dynamics and a micro-cap market capitalisation, positioning the stock as a potential contender for cautious accumulation."
      },
      {
        "title": "Bal Pharma Ltd Gains 21.37%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-gains-2137-5-key-factors-driving-the-surge-4191559",
        "imagepath": "",
        "date": "2026-09-12 16:00:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> Technical upgrade to Hold rating announced, stock closes at Rs.92.84 (+4.84%)</p>\n                    <p><strong>9 Sep:</strong> Hits new 52-week high at Rs.104.96 and surges to upper circuit closing at Rs.114.45 (+19.99%)</p>\n                    <p><strong>10 Sep:</strong> Reaches fresh 52-week high of Rs.124.68, despite a minor pullback (-6.73%)</p>\n                    <p><strong>11 Sep:</strong> Week closes at Rs.107.47 (+1.05%), maintaining strong momentum</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.88.55</div></div>\n             ..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bal Pharma Ltd to 52-Week High of Rs 124.68",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-hits-new-52-week-high-at-rs12468-4188889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_priceRelatedfactors_4188889.png",
        "date": "2026-09-10 09:46:45",
        "description": "With a 27.29% gain over the past year, Bal Pharma Ltd has surged to a fresh 52-week high of Rs 124.68 on 10 Jun 2026, outpacing the Sensex which declined by 8.20% over the same period. This milestone reflects a sustained upward momentum underpinned by a strong alignment of technical indicators across multiple timeframes."
      },
      {
        "title": "Bal Pharma Ltd Valuation Improves Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-improves-amid-strong-price-rally-4188405",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_valuationdot_4188405.png",
        "date": "2026-09-10 08:00:35",
        "description": "Bal Pharma Ltd has witnessed a significant shift in its valuation parameters, moving from a very attractive to an attractive grade, driven by a robust price surge and improving financial metrics. This re-rating comes as the pharmaceutical micro-cap stock outperforms the broader market, signalling renewed investor interest and a potential inflection point in its market perception."
      },
      {
        "title": "Bal Pharma Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4188195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_stocks_hitting_upper_circuit_4188195.png",
        "date": "2026-09-09 12:00:08",
        "description": "At Rs 114.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bal Pharma Ltd locked at its upper circuit of 20% on 09 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bal Pharma Ltd to 52-Week High of Rs 104.96",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-hits-new-52-week-high-at-rs10496-mark-4187625",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_priceRelatedfactors_4187625.png",
        "date": "2026-09-09 09:53:32",
        "description": "With a decisive break above Rs 104.96 on 09 Jun 2026, Bal Pharma Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes amid a backdrop of sustained gains over the past five trading sessions, where the stock has appreciated by over 20%, outpacing its sector and broader market indices."
      },
      {
        "title": "Bal Pharma Ltd Upgraded to Hold as Technicals Improve and Valuation Attractiveness Increases",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-attractiveness-increases-4185914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_mojoScore_4185914.png",
        "date": "2026-09-08 08:26:51",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite flat financial performance in the recent quarter. Investors are advised to consider the nuanced developments across quality, valuation, financial trends, and technicals before making decisions."
      }
    ],
    "total": 173,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Clarification Regarding Movement In Price",
      "datetime": "10-Sep-2026",
      "details": "Clarification regarding Movement in Price asper attachment",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Bal Pharma Ltd",
      "datetime": "10-Sep-2026",
      "details": "The Exchange has sought clarification from Bal Pharma Ltd on September 10 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "07-Sep-2026",
      "details": "Confirming the Allotment of Convertible Warrants on Preferential basis",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 17 Sep 26",
          "dt": "2026-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd is Rated Hold by MarketsMOJO

2026-09-24 10:11:20

Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd Valuation Shift Signals Renewed Price Attractiveness

2026-09-23 08:00:24

Bal Pharma Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a more favourable price point relative to its historical and peer benchmarks. This recalibration comes amid a mixed performance in the Pharmaceuticals & Biotechnology sector, with Bal Pharma’s micro-cap status and recent market movements positioning it as a stock worthy of closer investor scrutiny.

Read full news article

Bal Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-09-16 08:00:51

Bal Pharma Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors within the Pharmaceuticals & Biotechnology sector. This upgrade comes amid mixed sector dynamics and a micro-cap market capitalisation, positioning the stock as a potential contender for cautious accumulation.

Read full news article

Bal Pharma Ltd Gains 21.37%: 5 Key Factors Driving the Surge

2026-09-12 16:00:47

Key Events This Week

7 Sep: Technical upgrade to Hold rating announced, stock closes at Rs.92.84 (+4.84%)

9 Sep: Hits new 52-week high at Rs.104.96 and surges to upper circuit closing at Rs.114.45 (+19.99%)

10 Sep: Reaches fresh 52-week high of Rs.124.68, despite a minor pullback (-6.73%)

11 Sep: Week closes at Rs.107.47 (+1.05%), maintaining strong momentum

Week Open

Rs.88.55

...

Read full news article

Broad-Based Technical Strength Lifts Bal Pharma Ltd to 52-Week High of Rs 124.68

2026-09-10 09:46:45

With a 27.29% gain over the past year, Bal Pharma Ltd has surged to a fresh 52-week high of Rs 124.68 on 10 Jun 2026, outpacing the Sensex which declined by 8.20% over the same period. This milestone reflects a sustained upward momentum underpinned by a strong alignment of technical indicators across multiple timeframes.

Read full news article

Bal Pharma Ltd Valuation Improves Amid Strong Price Rally

2026-09-10 08:00:35

Bal Pharma Ltd has witnessed a significant shift in its valuation parameters, moving from a very attractive to an attractive grade, driven by a robust price surge and improving financial metrics. This re-rating comes as the pharmaceutical micro-cap stock outperforms the broader market, signalling renewed investor interest and a potential inflection point in its market perception.

Read full news article

Bal Pharma Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent

2026-09-09 12:00:08

At Rs 114.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bal Pharma Ltd locked at its upper circuit of 20% on 09 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Bal Pharma Ltd to 52-Week High of Rs 104.96

2026-09-09 09:53:32

With a decisive break above Rs 104.96 on 09 Jun 2026, Bal Pharma Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes amid a backdrop of sustained gains over the past five trading sessions, where the stock has appreciated by over 20%, outpacing its sector and broader market indices.

Read full news article

Bal Pharma Ltd Upgraded to Hold as Technicals Improve and Valuation Attractiveness Increases

2026-09-08 08:26:51

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite flat financial performance in the recent quarter. Investors are advised to consider the nuanced developments across quality, valuation, financial trends, and technicals before making decisions.

Read full news article

View All News